is exendin-4 in tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor: Cell Metabolism Designing GLP-1 delivery: structural perspectives

Timing: Administer once weekly, on the same day each week

GLP-1 medications are particularly beneficial in this overlap population because they address the insulin resistance that drives both conditions

A total of 59.9% of randomized patients completed the study regardless of whether they continued taking their assigned treatment (52.9% placebo, 61.0% phen/top ER 3.75/23 mg, 66.4% phen/top ER 15/92 mg

27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the first medication for certain patients with the condition

References Centers for Medicare & Medicaid Services (CMS)